Source: Annual Congress 2001 - Smoking cessation: predictors and interventions
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. I. van Spiegel, K. Lewis, G. Seinost, C. Astbury, A. Hider, R. Sweet (Amsterdam, The Netherlands; Shrewsbury, Greenford, United Kingdom; Graz, Austria). Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study. Eur Respir J 2001; 16: Suppl. 31, 177

Member's Comments

No comment yet.

Related content which might interest you: Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001 Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease. 12 month follow-up phase data (ZYB40014) Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002 Bupropion hydrochloride (Zyban™) is effective and well tolerated as an aid to smoking cessation - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 11s Year: 2001 The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002 The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001 Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Smoking cessation and prevention Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242 Year: 2006 Efficacy of bupropion SR in a smoking cessation programme for heavy smokers: preliminary results Source: Eur Respir J 2001; 18: Suppl. 33, 167s Year: 2001 Cytisine is an effective smoking cessation medication: more evidence now than ever before Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes Year: 2017 Smoking cessation and COPD Source: Eur Respir Rev 2013; 22: 37-43 Year: 2013 Pharmacological treatment for smoking cessation Source: Eur Respir Mon; 2008: 42: 74–97 Year: 2008 Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers Year: 2013 The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 Evaluation of prolonged bupropion treatment as an aid in smoking cessation Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002 Intervention study to evaluate effectiveness of integrated therapy (varenicline plus montivational interviewing) for smoking cessation in diabetic patients: Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake Year: 2012 Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 156s Year: 2004 Smoking cessation interventions in COPD: a network meta-analysis of randomised trials Source: Eur Respir J 2009; 34: 634 Year: 2009 Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008